Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Intrinsic Value
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese medicines. [ Read More ]
The intrinsic value of one
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
stock under the Base Case scenario is
172.28
CNY.
Compared to the current market price of 242.98 CNY,
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
is
Overvalued by 29%.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
Zhangzhou Pientzehuang Pharmaceutical Co Ltd or that its price is influenced by factors unrelated to fundamentals.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's market capitalization is 146.6B CNY.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock price is 242.98 CNY.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock (172.28 CNY) is 29% less than its price (242.98 CNY).
Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock (189.69 CNY) is 22% less than its price (242.98 CNY). Open DCF Valuation
Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock (154.87 CNY) is 36% less than its price (242.98 CNY). Open Relative Valuation
Zhangzhou Pientzehuang Pharmaceutical Co Ltd has upside potential of 20% compared to the average analyst price target.
Open Wall St Estimates
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's ROE (Return on Equity) has increased in the last 3 years from 23% to 25%.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 36% to 34%.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Revenue has grown by 14% over the past 12 months.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 25%.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Revenue is forecast to grow at a rate of 16% per year over the next 3 years.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Revenue has been growing by 14% per year for the last 3 years.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 34%.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd has positive Net Income for the last twelve months.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd has positive Operating Income for the last twelve months.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd has positive three-year average ROE (Return on Equity): 25%. The company is efficient at transforming stockholders' equity into net income.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd has positive Gross Profit for the last twelve months.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd has very high three-year average ROIC (Return on Invested Capital): 35%. The company is very efficient at using invested capital to generate operating income.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd has positive Free Cash Flow for the last twelve months.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.09.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's short-term assets (14B CNY) exceed its short-term liabilties (3B CNY).
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's long-term assets (16B CNY) exceed its long-term liabilties (4B CNY).
Zhangzhou Pientzehuang Pharmaceutical Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (10B CNY) than debt (1B CNY).
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Altman Z-Score is very high and is equal to 28.73.
Valuation Backtest
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Balance Sheet Decomposition
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
| Current Assets | 14B |
| Cash & Short-Term Investments | 9.9B |
| Receivables | 1.1B |
| Other Current Assets | 3B |
| Non-Current Assets | 1.9B |
| Long-Term Investments | 658.9m |
| PP&E | 723.2m |
| Intangibles | 309.3m |
| Other Non-Current Assets | 223.7m |
| Current Liabilities | 3B |
| Accounts Payable | 350.1m |
| Accrued Liabilities | 468.7m |
| Short-Term Debt | 1B |
| Other Current Liabilities | 1.1B |
| Non-Current Liabilities | 807m |
| Long-Term Debt | 118m |
| Other Non-Current Liabilities | 689m |
Earnings Waterfall
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
|
Revenue
|
9.7B
CNY
|
|
Cost of Revenue
|
-5.3B
CNY
|
|
Gross Profit
|
4.4B
CNY
|
|
Operating Expenses
|
-1.2B
CNY
|
|
Operating Income
|
3.3B
CNY
|
|
Other Expenses
|
-430.1m
CNY
|
|
Net Income
|
2.8B
CNY
|
Free Cash Flow Analysis
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
Score
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Zhangzhou Pientzehuang Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
is 291.33 CNY
with a low forecast of 191.9 CNY and a high forecast of 344.4 CNY.
Shareholder Return
Price
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
| Average Annual Return | 44.88% |
| Standard Deviation of Annual Returns | 83.56% |
| Max Drawdown | -61% |
| Market Capitalization | 146.6B CNY |
| Shares Outstanding | 603 317 210 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese medicines. The company is headquartered in Zhangzhou, Fujian and currently employs 2,591 full-time employees. The company went IPO on 2003-06-16. The firm is also engaged in the production and sales of cosmetics and daily chemical products and the circulation of medicine. The firm's core products are PianZi Huang series products, including PianZi Huang, PianZi Huang capsule, compound PianZi Huang buccal tablets, compound PianZi Huang ointment, compound PianZi Huang hemorrhoids ointment and others, covering many fields such as liver disease medication, cold medication, dermatology medication. The firm's products are sold to domestic and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
stock under the Base Case scenario is
172.28
CNY.
Compared to the current market price of 242.98 CNY,
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
is
Overvalued by 29%.
You don't have any saved screeners yet
